Diagnostic Imaging: Nuclear Medicine: 3ed

Reflects recent advances in the field with information on new guidelines, new imaging protocols and equipment, and new radiotracers -including I-131 therapy for thyroid cancer; new tracers for PET/CT for prostate cancer, carcinoid tumor, pancreatic neuroendocrine tumors, and many more; new procedures for GI motility; new SPECT/CT protocols for sentinel lymph node mapping, parathyroid adenoma, pulmonary embolism, and more Contains new chapters on approach to nuclear medicine therapy, Lu-177 Dotatate therapy for SRS positive tumors, Lu-177 PSMA therapy for prostate cancer, GFR Analysis, pulmonary carcinoid tumor, meningioma, and pediatric CNS and neuroendocrine tumors Details new targeted nuclear medicine therapies, including theranostics: using one radioactive drug to diagnose and a second radioactive drug to deliver therapy to treat a main tumor and any metastatic tumors